NeuroLogic Spring 2011
Articles in this Issue
Hopkins doctors work together to diagnose and treat patients with this unusual condition.
Clinical trials for the following conditions are actively recruiting patients: primary progressive multiple sclerosis (PPMS), Parkinson's disease psychosis, Parkinson's disease, normal learning and memory, amnesia, headache, peripheral neuropathy, and ischemic stroke.
NeuroPace, an experimental device expected to receive FDA approval soon, prevents seizures by sensing abnormal electrical activity and delivering a competing burst of electricity.
Through clinical and laboratory research, spinal muscular atrophy has gone from one of the most hopeless of all neuromuscular diseases to one of the most hopeful.
Hopkins neurosurgeons are increasingly taking advantage of minimally invasive surgical techniques.
Argye Hillis and Jon Weingart are part of a comprehensive team that evaluates and treats traumatic brain injury patients and steers them to resources for long-term therapy.